by sfrazee | Apr 26, 2024
By Tomas J. Philipson April 26, 2024 Both the Left and the Right need a better understanding of how product improvements through novel innovation work. For decades, progressives have fought to weaken America’s world-leading protections for property rights....
by sfrazee | Apr 12, 2024
By Tomas J. Philipson April 12, 2024 In their April 9 op-ed, “Big Pharma’s high prices don’t drive innovation,” Avik Roy and Gregg Girvan argued that Medicare’s new authority to demand lower prices from drug manufacturers will not result in the development and...
by sfrazee | Mar 21, 2024
By Tomas J. Philipson & Casey B. Mulligan March 21, 2024 Public health frequently trivializes prevention costs, and therefore misjudges the overall effects of disease policies. This month marks the fourth anniversary of the proclamation on March 13, 2020,...
